Lambipol (Lamotrigine)

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal excitability.

• Epilepsy: Reduces frequency and severity of partial and generalized seizures.
• Bipolar disorder: Helps prevent recurrence of manic and depressive episodes.

• Lamotrigine inhibits voltage‑gated sodium channels in neuronal membranes, decreasing the influx of sodium ions during depolarization. This stabilizes neuronal excitability and reduces the release of excitatory neurotransmitters such as glutamate. By limiting excessive neuronal firing, the drug diminishes seizure propagation and moderates mood swings associated with bipolar disorder. The effect is use‑dependent, meaning it preferentially blocks channels that are frequently opened, which contributes to its efficacy in rapidly firing neuronal circuits.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dizziness: Light‑headed feeling or loss of balance.
• Headache: Mild to moderate pain in the head.
• Nausea: Feeling of stomach upset or urge to vomit.
• Rash: Skin redness or mild itching.
• Fatigue: Generalized tiredness or lack of energy.
• Blurred vision: Temporary visual disturbances.
• Insomnia: Difficulty falling or staying asleep.
• Tremor: Involuntary shaking of hands or limbs.

Serious or Rare Side Effects

• Stevens‑Johnson syndrome: Severe skin reaction with blistering and mucosal involvement.
• Toxic epidermal necrolysis: Life‑threatening skin detachment.
• Aseptic meningitis: Inflammation of the meninges without infection.
• Hematologic abnormalities: Low white blood cell or platelet counts.
• Severe hypersensitivity: Swelling of face, lips, or throat.
• Liver injury: Elevated enzymes or hepatitis.

When prescribing Lamotrigine, clinicians should consider several safety measures.

• Initiate therapy gradually: Start with low dose and increase slowly to reduce rash risk.
• Monitor skin reactions: Discontinue immediately if a rash develops.
• Assess hepatic function: Use caution in patients with liver impairment.
• Review concomitant medications: Adjust dose when combined with enzyme‑inducing drugs.
• Avoid use in patients with known hypersensitivity to lamotrigine.
• Store at ambient temperature below 25°C: Keep in original packaging, protect from moisture and light.

Lamotrigine interacts with several drugs that can alter its plasma levels or increase adverse effects.

Major Interactions (Avoid)

• Valproic acid: Increases lamotrigine levels, risk of toxicity; dose reduction required.
• Carbamazepine: Decreases lamotrigine levels, may reduce efficacy; dose increase may be needed.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: Decrease lamotrigine clearance, may raise concentrations; monitor for side effects.
• Phenobarbital: Lowers lamotrigine levels, may require dose adjustment.
• Phenytoin: Reduces lamotrigine concentrations, monitor seizure control.
• Rifampicin: Increases metabolism of lamotrigine, may diminish effect.